Key result
A re-emerging recombinant GII.P16-GII.2 norovirus variant was associated with 73.4% of acute gastroenteritis outbreaks in Jiangsu, China, predominantly occurring in February and March of 2017.
Observational (n=2,953)
Yes
A re-emerging GII.P16-GII.2 norovirus variant with unique mutations in RdRp and VP1 regions was responsible for a significant increase in acute gastroenteritis outbreaks in Jiangsu, China in early 2017.
May prompt seasonal surveillance for norovirus outbreaks; leaves open questions on variant evolution and control measures.
A total of 64 acute gastroenteritis outbreaks with 2,953 patients starting in December of 2016 and occurring mostly in the late spring of 2017 were reported in Jiangsu, China. A recombinant GII.P16-GII.2 norovirus variant was associated with 47 outbreaks (73.4%) for the gastroenteritis epidemic, predominantly occurring in February and March of 2017. Sequence analysis of the RNA-dependent RNA polymerase (RdRp) and capsid protein of the viral isolates from these outbreaks confirmed that this GII.P16-GII.2 strain was the GII.P16-GII.2 variant with the intergenotypic recombination, identified in Taiwan, Hong Kong, and other cities in China in 2016. This GII.P16-GII.2 recombinant variant appeared to a re-emerging strain, firstly identified in 2011-2012 from Japan and USA but might be independently originated from other GII.P16-GII.2 variants for sporadic and outbreaks of gastroenteritis in Japan and China before 2016. Further identification of unique amino acid mutations in both VP1 and RdRp of NoV strain as shown in this report may provide insight in explaining its structural and antigenic changes, potentially critical for the variant recombinant to gain its predominance in causing regional and worldwide epidemics.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2017) conducted an observational in Acute gastroenteritis (n=2,953). GII.P16-GII.2 norovirus vs. Other norovirus genotypes was evaluated on Proportion of acute gastroenteritis outbreaks associated with the GII.P16-GII.2 norovirus variant. A re-emerging recombinant GII.P16-GII.2 norovirus variant was associated with 73.4% of acute gastroenteritis outbreaks in Jiangsu, China, predominantly occurring in February and March of 2017.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: